Chargement en cours...
Sodium Iodide Symporter (NIS) in the Management of Patients with Thyroid Carcinoma
Although radioiodine has been applied in thyroid diseases including carcinoma for over 70 years, it was only in 1996 that the basic molecular mechanism of iodine uptake was identified. Iodide is actively transported into the thyroid via a membrane glycoprotein known as sodium iodide symporter (NIS)....
Enregistré dans:
| Publié dans: | Nucl Med Mol Imaging |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer Berlin Heidelberg
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6177348/ https://ncbi.nlm.nih.gov/pubmed/30344779 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13139-018-0540-y |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|